[go: up one dir, main page]

DK0889051T3 - Triterpenderivater og midler mod leversygdomme - Google Patents

Triterpenderivater og midler mod leversygdomme

Info

Publication number
DK0889051T3
DK0889051T3 DK97903610T DK97903610T DK0889051T3 DK 0889051 T3 DK0889051 T3 DK 0889051T3 DK 97903610 T DK97903610 T DK 97903610T DK 97903610 T DK97903610 T DK 97903610T DK 0889051 T3 DK0889051 T3 DK 0889051T3
Authority
DK
Denmark
Prior art keywords
remedies
liver disease
triterpene derivatives
triterpene
derivatives
Prior art date
Application number
DK97903610T
Other languages
Danish (da)
English (en)
Inventor
Kazue Sasaki
Nobuto Minowa
S Nishiyama
H Kuzuhara
Original Assignee
Meiji Seika Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Co filed Critical Meiji Seika Co
Application granted granted Critical
Publication of DK0889051T3 publication Critical patent/DK0889051T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK97903610T 1996-02-26 1997-02-26 Triterpenderivater og midler mod leversygdomme DK0889051T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3782996 1996-02-26
PCT/JP1997/000555 WO1997031014A1 (fr) 1996-02-26 1997-02-26 Derives triterpeniques et remedes pour maladies hepatiques

Publications (1)

Publication Number Publication Date
DK0889051T3 true DK0889051T3 (da) 2001-10-15

Family

ID=12508425

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97903610T DK0889051T3 (da) 1996-02-26 1997-02-26 Triterpenderivater og midler mod leversygdomme

Country Status (14)

Country Link
US (3) US6201018B1 (fr)
EP (1) EP0889051B1 (fr)
JP (1) JP3727353B2 (fr)
KR (1) KR100400601B1 (fr)
CN (1) CN100334104C (fr)
AU (1) AU1811597A (fr)
BR (1) BR9707601A (fr)
CA (1) CA2247327A1 (fr)
DE (1) DE69706037T2 (fr)
DK (1) DK0889051T3 (fr)
ES (1) ES2161439T3 (fr)
RU (1) RU2168517C2 (fr)
TW (1) TW505653B (fr)
WO (1) WO1997031014A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100530278B1 (ko) * 1997-02-28 2006-04-06 동국제약 주식회사 아시아트산 유도체를 유효성분으로 하는 간 보호 및치료제
RU2210373C1 (ru) * 2002-07-03 2003-08-20 Государственное учреждение Тверская государственная медицинская академия Способ лечения тяжелого и затяжного течения острого вирусного гепатита
RU2264820C2 (ru) * 2004-01-15 2005-11-27 Общество с ограниченной ответственностью "Березовый мир" Средство для профилактики вирусного гепатита c
RU2244554C1 (ru) * 2003-08-28 2005-01-20 Общество с органиченной ответственностью "БЕРЕЗОВЫЙ МИР" Средство для лечения вирусного гепатита с
WO2005021007A1 (fr) * 2003-08-28 2005-03-10 Obschestvo S Ogranichennoi Otvetstvennostju 'berezovy Mir' Prevention et traitement de l'hepatite virale b
US20060293388A1 (en) * 2003-10-02 2006-12-28 Universidade Federal Do Rio De Janeiro Pomolic acid, its isomers, derivatives and their uses, pharmaceutical composition, method to prepare the pharmaceutical composition and method for treating multidrug resistant tumours
CN102656181A (zh) * 2009-12-15 2012-09-05 明治制果药业株式会社 三萜衍生物及用于预防或治疗c型慢性肝炎的药剂
TW201136946A (en) * 2009-12-15 2011-11-01 Meiji Seika Kaisha Prophylactic or therapeutic agent for chronic hepatitis c
WO2012133733A1 (fr) * 2011-03-30 2012-10-04 学校法人久留米大学 Inhibiteur de prolifération de cellules cancéreuses
US20120307467A1 (en) * 2011-06-03 2012-12-06 Navarro Luis A Oxygen-Barrier Packaged Surface Mount Device
CN103889434B (zh) 2011-06-21 2017-02-15 Bvw控股公司 含有乳香酸的医疗装置
AU2013251310B2 (en) 2012-04-27 2018-02-15 Cytomx Therapeutics, Inc. Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
US9540440B2 (en) 2013-10-30 2017-01-10 Cytomx Therapeutics, Inc. Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
US9737623B2 (en) 2013-12-11 2017-08-22 Cytomx Therapeutics, Inc. Antibodies that bind activatable antibodies and methods of use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU528415B2 (en) * 1978-03-31 1983-04-28 Otsuka Pharmaceutical Co., Ltd. Anticomplementary agents
JPS6185344A (ja) 1984-10-03 1986-04-30 Otsuka Pharmaceut Co Ltd トリテルペン誘導体
US5064823A (en) * 1988-08-24 1991-11-12 Research Triangle Institute Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers
US4891221A (en) * 1988-11-23 1990-01-02 Edward Shanborm Whole blood antiviral process and composition
US4987151A (en) * 1989-06-19 1991-01-22 The Trustees Of Columbia University In The City Of New York Triterpene derivatives cholesterol acyltransferase inhibitors and methods of using same
JPH07583B2 (ja) * 1990-11-21 1995-01-11 北海道糖業株式会社 水溶性五環性トリテルペン包接化合物及びその製造方法並びにそれを利用した食品、飲料、口腔用組成物
US5723149A (en) * 1990-11-21 1998-03-03 Lvmh Recherche Use of medicago saponins for the preparation of cosmetic or pharmaceutical compositions, especially dermatological compositions, promoting renewal of the epidermis, stimulating hair regrowth or delaying hair loss
FR2669225B1 (fr) 1990-11-21 1993-11-12 Lvmh Recherche Gie Utilisation de saponines de medicago pour la preparation de compositions cosmetiques ou pharmaceutiques, notamment dermatologiques.
RU2029554C1 (ru) * 1991-06-27 1995-02-27 Мамадов Юсупджан Маматжанович Вещество, обладающее желчегонной и гепатопротекторной активностями
GB9116601D0 (en) * 1991-08-01 1991-09-18 Iaf Biochem Int 1,3-oxathiolane nucleoside analogues
WO1997003088A1 (fr) 1995-07-07 1997-01-30 Meiji Seika Kabushiki Kaisha Derives triterpenes et medicament pour les maladies du foie
US5650167A (en) * 1995-11-16 1997-07-22 Dawa Incorporated Method and composition for treating hepatitis B

Also Published As

Publication number Publication date
ES2161439T3 (es) 2001-12-01
RU2168517C2 (ru) 2001-06-10
TW505653B (en) 2002-10-11
CN100334104C (zh) 2007-08-29
DE69706037T2 (de) 2002-06-06
BR9707601A (pt) 2000-01-04
KR19990087275A (ko) 1999-12-15
EP0889051A4 (fr) 1999-06-16
CA2247327A1 (fr) 1997-08-28
AU1811597A (en) 1997-09-10
JP3727353B2 (ja) 2005-12-14
US6201018B1 (en) 2001-03-13
US20030195182A1 (en) 2003-10-16
DE69706037D1 (de) 2001-09-13
US20020016481A1 (en) 2002-02-07
WO1997031014A1 (fr) 1997-08-28
EP0889051B1 (fr) 2001-08-08
US7153979B2 (en) 2006-12-26
CN1212702A (zh) 1999-03-31
KR100400601B1 (ko) 2004-02-18
EP0889051A1 (fr) 1999-01-07
US6593364B2 (en) 2003-07-15

Similar Documents

Publication Publication Date Title
DE69513671D1 (de) Arzneimittel
DE69737936D1 (de) Arzneimittel
NO984107D0 (no) Kappa agnostiske forbindelser og farmasöytiske ormuleringer derav
ATE225784T1 (de) Indan- oder dihydroindolderivate
BR9509530A (pt) Composições farmacêuticas
NO20011157D0 (no) Benzenderivater og farmasøytisk anvendelse derav
DK0879824T3 (da) Triterpenderivater og middel mod leversygdom
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
DK0889051T3 (da) Triterpenderivater og midler mod leversygdomme
NO20004277D0 (no) Indolderivater og farmasøytiske sammensetninger omfattende det samme
BR9508110A (pt) Derivado de triterpeno e composição médica
BR9509688A (pt) Composto e composição farmacêutica
BR9507768A (pt) Composição farmacêutica
ID16781A (id) Formulasi-formulasi farmasi
DZ1926A1 (fr) Formulations pharmaceutiques.
FI961915L (fi) Antrasykliinijohdannaiset
EE9800209A (et) Antiglükokortikoidne ravimaine
ITMI941169A0 (it) Formulazioni farmaceutiche
ID18698A (id) Komposisi farmasi
DK1066261T3 (da) Pyridinderivat og farmaceutisk præparat indeholdende samme
EP0923564A4 (fr) Composes pharmaceutiques
FI951155L (fi) Farmaseuttinen valmiste
FI961364L (fi) Lääkeainekoostumus
ITMI962628A0 (it) Composizione farmaceutica
NO985572L (no) Substituerte amidinobenzenderivater og medisinske preparater derav